Melanoma International Collaborative Adaptive Trials: Progress Report
The first adaptive platform trial in melanoma—and one of the only adaptive platform trials that will be in existence for…
Melanoma International Collaborative Adaptive Trials: Progress Report
The first adaptive platform trial in melanoma—and one of the only adaptive platform trials that will be in existence for…
,
,
Tanya Lafontaine, Melanoma Survivor: “I’ve Got This”
…have melanoma, neither should you. Lafontaine was originally diagnosed with Stage II melanoma on July 25, 2016. After the cancer…
,
Melanoma by the State: North Dakota
…the community. They selected melanoma in 2018. Work began immediately. Right away, they felt that a patient story would impact…
,
Immunotherapy treatment may be appropriate for patients with earlier stages of melanoma
Source: University of Pittsburgh (September 20, 2021) An immunotherapy called pembrolizumab reduced cancer recurrence after surgery in patients with stage…
,
,
Walking to Conquer Melanoma: Mike’s Miracle Workers
By Mara Klecker Even when the pandemic forced the KDB Melanoma 5k Walk/Run to go virtual in 2020, Mike’s Miracle…
,
,
Shannon Eberly, Stage IV Melanoma Survivor- Sharing is Everything
By Mara Klecker Shannon Eberly is fair-skinned and freckled, but she never had a mole on her skin that looked…
,
Steve Banks, Stage III Survivor, Doesn’t Let Melanoma Define His Life
…doctors removed his primary site of melanoma about a decade ago. “I’m an upfront and honest person,” Steve said. “But…
,
Regeneron Reports Fianlimab plus Libtayo Showed Above 60% Response Rate in Patients with Advanced Melanoma Naïve to PD-1 or PD-L1 Inhibitors
…melanoma,” said Israel Lowy, M.D., Ph.D., Senior Vice President, Translational and Clinical Sciences, Oncology at Regeneron. “Combining LAG-3 and PD-1…
,
Diagnosed with Melanoma as a Teenager Changed My Life’s Course
…than 1% of all new cases of melanoma. Madison’s doctor said she was the youngest melanoma patient he’d ever treated.…
,
Iovance Biotherapeutics Announces Updated Clinical Data for Lifileucel in Advanced Melanoma at Society for Immunotherapy of Cancer (SITC) Annual Meeting
(November 07, 2022 08:01 ET | Source: Iovance Biotherapeutics, Inc. ) Clinically Meaningful and Durable Activity in Largest Cell Therapy…
,
,
Recent Posts
Mar. 26, 2026
Wade Watson, Stage III Melanoma Survivor: A Marathon, Not a Sprint
Mar. 03, 2026
Cancer is More Than a Diagnosis: Mind, Meaning, and Healing
Feb. 19, 2026
Merlin CP-GEP Becomes the First and Only Gene Expression Profile Test Recommended by NCCN®
Feb. 05, 2026
Best-in-Class Real-World Data Support Early Amtagvi® Treatment in Advanced Melanoma
Jan. 23, 2026